I'm not doing anything til I see the quarterly. Expecting ongoing improvements during commissioning, and the con spec is actually not bad now from the last update.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025